Cargando…

Correction to: Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing

Detalles Bibliográficos
Autores principales: Eguizabal, C., Herrera, L., Inglés-Ferrándiz, M., Belmonte, J. C. Izpisua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080394/
https://www.ncbi.nlm.nih.gov/pubmed/33906672
http://dx.doi.org/10.1186/s13287-021-02281-1
_version_ 1783685416835088384
author Eguizabal, C.
Herrera, L.
Inglés-Ferrándiz, M.
Belmonte, J. C. Izpisua
author_facet Eguizabal, C.
Herrera, L.
Inglés-Ferrándiz, M.
Belmonte, J. C. Izpisua
author_sort Eguizabal, C.
collection PubMed
description
format Online
Article
Text
id pubmed-8080394
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80803942021-04-29 Correction to: Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing Eguizabal, C. Herrera, L. Inglés-Ferrándiz, M. Belmonte, J. C. Izpisua Stem Cell Res Ther Correction BioMed Central 2021-04-27 /pmc/articles/PMC8080394/ /pubmed/33906672 http://dx.doi.org/10.1186/s13287-021-02281-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Eguizabal, C.
Herrera, L.
Inglés-Ferrándiz, M.
Belmonte, J. C. Izpisua
Correction to: Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing
title Correction to: Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing
title_full Correction to: Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing
title_fullStr Correction to: Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing
title_full_unstemmed Correction to: Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing
title_short Correction to: Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing
title_sort correction to: treating primary immunodeficiencies with defects in nk cells: from stem cell therapy to gene editing
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080394/
https://www.ncbi.nlm.nih.gov/pubmed/33906672
http://dx.doi.org/10.1186/s13287-021-02281-1
work_keys_str_mv AT eguizabalc correctiontotreatingprimaryimmunodeficiencieswithdefectsinnkcellsfromstemcelltherapytogeneediting
AT herreral correctiontotreatingprimaryimmunodeficiencieswithdefectsinnkcellsfromstemcelltherapytogeneediting
AT inglesferrandizm correctiontotreatingprimaryimmunodeficiencieswithdefectsinnkcellsfromstemcelltherapytogeneediting
AT belmontejcizpisua correctiontotreatingprimaryimmunodeficiencieswithdefectsinnkcellsfromstemcelltherapytogeneediting